BSECompany Update11 Aug 2026 · 11 Aug 2026, 05:00 pm

Statement of Deviation and Variation for the Quarter Ended 30th June, 2026

JHS Svendgaard Laboratories Ltd · 532771

✦ AI Summary

JHS Svendgaard Laboratories Ltd has filed a statement of deviation and variation for the quarter ended June 30, 2026, under Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, regarding the utilization of funds raised through a preferential issue.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

JHS Svendgaard Laboratories Ltd - 532771 - Statement Of Deviation & Variation

Attachments (1)

📄

bc9cea92-e09e-42fd-8319-2bcdeb99b6f1.pdf

pdf

Download →
View document text
CIN:L74110HP2004PLC027558 To August 11, 2026 The Listing Department The Listing Department Bombay Stock Exchange Limited National Stock Exchange of India Limited Department of Corporate Services Exchange Plaza, C-1, Block-G Phiroze Jeejeebhoy Towers, Bandra Kurla Complex Dalal Street, Mumbai – 400001 Mumbai – 400051 Scrip Code: 532771 Trading Symbol: JHS Subject: Statement of Deviation or Variation under Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 for the Quarter ended June 30, 2026. Dear Sir, Pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Statement of Deviation or Variation for the quarter ended June 30, 2026, in respect of the utilization of funds raised through Preferential Issue by the Company, as approved by the Board of Directors at its meeting held on August 11, 2026. This information is available on the website of the Company viz., www.svendgaard.com. Kindly take the same on records. Thanking You, For JHS Svendgaard Laboratories Limited Komal Jha Company Secretary & Compliance officer Encl: A/a CIN:L74110HP2004PLC027558 ANNEXURE-A Statement of Deviation / Variation in utilization of Funds Raised Particulars Details Name of listed entity JHS Svendgaard Laboratories Limited Mode of Fund Raising Preferential Issue Date of Raising Funds 04th June 2024 Amount Raised Rs. 29.99 crores Report filed for Quarter ended June 30, 2026 Monitoring Agency N.A. Monitoring Agency Name, if N.A. applicable Is there a Deviation / Variation in use of funds raised If yes, whether the same is pursuant to change in terms of a contract or N.A. objects, which was approved by the shareholders If Yes, Date of shareholder Approval 04th July, 2024 Explanation for the Deviation / Variation Comments of the Audit Committee after review Comments of the auditors, if any NIL CIN:L74110HP2004PLC027558 Amount of Modified Deviation/Variation Original Funds Sr. No. Original Object Modified Object, if any allocation, for the quarter Allocation Utilised if any according to applicable object 1 For Setting Up new Fund the capital 2249.99 764.99 764.46 0.00 Project in Jammu & expenditure for Kashmir under acquiring equipment Industrial for Development manufacturing facility. Scheme (IDS) 2021- 2030, J&K 2 For General N.A. 750.00 0.00 749.50 0.00 Corporate Purpose 3 NA Infusion of funds in 0.00 1110.01 962.50 0.00 Group entity i.e. JHS Svendgaard Retail Ventures Ltd., for funding the expansion plan through strategic fund infusion